Genetic Approaches to Combat Avian Influenza in Poultry: Resilience, Resistance, and Reality

The poultry industry has long faced the persistent threat of avian influenza virus (AIV), a highly contagious pathogen capable of inflicting severe economic losses and posing significant zoonotic risks. The virus’s rapid mutation rates and ability to jump species barriers have complicated control measures. Traditional approaches such as biosecurity, vaccination, and mass culling have offered only limited success, particularly against highly pathogenic avian influenza (HPAI) strains. In light of these challenges, researchers have increasingly turned their focus towards genetic strategies that could potentially confer resistance or resilience in poultry populations. This blog explores the scientific advancements, challenges, and future prospects of developing genetically fortified chickens against AIV.

Understanding the Terminology: Resistance vs Resilience

In the context of AIV control, it is crucial to differentiate between genetic resistance and resilience:

• Genetic resistance refers to the inherent inability of an animal to become infected with AIV. Resistance prevents viral entry or replication and can effectively block disease transmission.
• Genetic resilience, on the other hand, enables birds to recover from infection with reduced morbidity and mortality. While the virus may still replicate, the host’s genetic makeup allows for better control of the disease and maintenance of productivity.

Both approaches offer unique advantages, but they also present distinct challenges when it comes to implementation in commercial poultry lines.

Key Genetic Factors Influencing AIV Response

1. Mx Gene (Myxovirus Resistance Protein)

The Mx gene encodes a GTPase involved in antiviral responses. In chickens, polymorphisms such as the S631N substitution have been linked to differential antiviral activity. While early studies suggested that the N631 variant conferred resistance, subsequent research has shown inconsistent results in vitro and in vivo (Chen et al., 2025).

1. ANP32A (Acidic Nuclear Phosphoprotein 32 Family Member A)

This gene is critical for influenza virus polymerase function. Gene editing to alter amino acids at positions 129 and 130 (N129I-D130N) has demonstrated partial resistance in chickens. However, high viral doses can still overcome this modification, and escape mutations have been observed, indicating the need for multi-target strategies (Chen et al., 2025).

1. Pattern Recognition Receptors (PRRs)

Toll-like receptors (TLR3 and TLR7) and RIG-I play crucial roles in recognizing viral RNA and initiating innate immune responses. Chickens lack RIG-I, unlike ducks, which may partly explain their higher susceptibility. Transgenic expression of duck RIG-I in chicken cells has shown reduced viral replication, highlighting its potential as a resilience factor (Chen et al., 2025).

1. Interferon-Stimulated Genes (ISGs)

IFIT and IFITM families are activated by interferons and have been implicated in inhibiting viral replication and entry. Notably, ducks show significantly higher expression of these genes upon AIV infection compared to chickens. Enhancing the expression or function of these genes in chickens could improve resilience (Chen et al., 2025).

1. SLC35A1 and GRM2

These genes are involved in viral entry via sialic acid transport and clathrin-mediated endocytosis, respectively. While they are promising targets, their essential physiological roles caution against complete knockout approaches (Chen et al., 2025).

1. MHC Haplotypes

Certain major histocompatibility complex (MHC) haplotypes, such as B21, are associated with improved survival following HPAI infection. However, they do not confer complete resistance, and their effect appears to be viral strain-dependent (Chen et al., 2025).

Strategies for Genetic Intervention

1. Selective Breeding

Breeding programs focusing on naturally occurring resistant or resilient traits, such as favorable MHC haplotypes or Mx variants, have shown promise. However, trade-offs with production traits and the complexity of polygenic resistance limit the effectiveness of this approach (Chen et al., 2025).

1. Gene Editing (CRISPR/Cas9)

Gene editing offers precise and rapid introduction of beneficial mutations. The ANP32A modification is a case in point, though its partial effectiveness underlines the need for multi-gene targeting. Safety, ethical considerations, and consumer acceptance are critical factors influencing the deployment of gene-edited poultry (Chen et al., 2025).

1. Transgenesis

This approach introduces foreign genes, such as duck RIG-I or antiviral short-hairpin RNAs, into the chicken genome. While initial studies have demonstrated reduced viral transmission, the technology is still in early stages and faces hurdles regarding uniform gene expression and potential off-target effects (Chen et al., 2025).

Challenges and Limitations

• Viral Evolution: AIV’s high mutation rate can render single-gene resistance ineffective over time.
• Physiological Trade-offs: Genetic modifications may impact essential functions, growth rates, or reproductive performance.
• Regulatory and Ethical Concerns: Widespread adoption of gene-edited or transgenic poultry depends on societal acceptance and legal frameworks.
• Complex Host-Pathogen Interactions: Resistance and resilience are likely polygenic traits influenced by environmental and immunological factors.

Lessons from Plant Pathology

The case of wheat resistance to rust pathogens provides valuable insights. Single-gene resistance often breaks down within a few years, whereas combining multiple partial resistance genes has yielded more durable results. A similar combinatorial approach may be essential for achieving sustained AIV control in poultry (Chen et al., 2025).

Future Directions

To progress toward genetically resilient or resistant poultry, researchers must:

• Identify and validate new genetic targets through genome-wide studies.
• Evaluate the trade-offs of selected traits in commercial settings.
• Develop integrated strategies that combine natural selection, gene editing, and transgenesis.
• Monitor viral evolution to adapt genetic strategies accordingly.
• Engage with regulators, producers, and the public to ensure acceptance and ethical compliance.

Conclusion

While a universally AIV-resistant chicken remains elusive, strides in genetic research offer realistic pathways to enhance disease resilience. A multifaceted approach—incorporating selective breeding, gene editing, and transgenic technologies—stands as the most viable path forward. The success of these strategies will hinge not only on scientific breakthroughs but also on their practical integration into poultry production systems without compromising productivity or animal welfare.

The road ahead is challenging, but with continued innovation and collaboration, genetic fortification of poultry against avian influenza could soon shift from a theoretical mirage to a tangible reality.

References

Chen, P. R., White, S. N., Walker, L. R., Kapczynski, D. R., & Suarez, D. L. (2025). Genetic resilience or resistance in poultry against avian influenza virus: mirage or reality? Journal of Virology, 10.1128/jvi.00820-25.